Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.